Profiel
T.
Gary Bird currently works at Veru, Inc., as Executive VP-Quality & Regulatory Affairs from 2020.
Dr. Bird also formerly worked at GTx, Inc., as Director-Corporate Quality.
Dr. Bird received his graduate degree from Mississippi State University.
Actieve functies van T. Bird
| Bedrijven | Functie | Begin |
|---|---|---|
| VERU INC. | Algemeen Adviseur | 01-01-2020 |
Eerdere bekende functies van T. Bird
| Bedrijven | Functie | Einde |
|---|---|---|
GTx, Inc.
 GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Corporate Officer/Principal | - |
Opleiding van T. Bird
| Mississippi State University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VERU INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
GTx, Inc.
GTx, Inc. Pharmaceuticals: MajorHealth Technology GTx, Inc. is a a biopharmaceutical company, which engages in the discovery, development, and commercialization of small molecules for the treatment of muscle-related diseases and other serious medical conditions. It focuses on developing selective androgen receptor modulators and selective androgen receptor degrader for the treatment of breast cancer, stress urinary incontinence, Duchenne muscular dystrophy, and prostate cancer. The company was founded by Marc Steven Hanover and Mitchell Shuster Steiner on September 24, 1997 and is headquartered in Memphis, TN. | Health Technology |
